Mitsubishi Ufj Trust & Banking Corp Upped Its Johnson & Johnson (JNJ) Stake by $22.61 Million

July 27, 2018 - By Megan Stone

Johnson & Johnson (NYSE:JNJ) LogoInvestors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Murphy Pohlad Asset Mgmt Ltd Limited Liability Company holds 19,492 shares or 1.72% of its portfolio. Jane Street Group Ltd stated it has 0.02% of its portfolio in Johnson & Johnson (NYSE:JNJ). Korea Invest Corp invested in 1.28% or 2.15M shares. Proshare Advsr Ltd Liability Corp has invested 1.02% in Johnson & Johnson (NYSE:JNJ). 22,484 were reported by Manchester Mgmt Ltd Liability Corp. Cacti Asset Mgmt Limited Company reported 2.95% stake. Legacy Private, a Wisconsin-based fund reported 45,833 shares. Magellan Asset Mngmt Limited has 0% invested in Johnson & Johnson (NYSE:JNJ) for 84 shares. 2,771 were reported by Hite Hedge Asset Mgmt Ltd Liability Com. 24,917 are held by Acropolis Inv Mngmt Ltd Liability Company. Fred Alger Mngmt stated it has 0.03% in Johnson & Johnson (NYSE:JNJ). Chase Invest Counsel Corp accumulated 0.14% or 2,160 shares. Lehman Fin Res accumulated 0.72% or 10,905 shares. Blume Cap Management invested in 59,643 shares. Daniel Devine And Communications holds 30,457 shares or 3.17% of its portfolio.

Since February 15, 2018, it had 0 insider purchases, and 1 sale for $20.17 million activity.

Mitsubishi Ufj Trust & Banking Corp increased its stake in Johnson & Johnson (JNJ) by 3.13% based on its latest 2018Q1 regulatory filing with the SEC. Mitsubishi Ufj Trust & Banking Corp bought 176,606 shares as the company’s stock declined 8.03% with the market. The institutional investor held 5.82 million shares of the major pharmaceuticals company at the end of 2018Q1, valued at $745.22M, up from 5.64 million at the end of the previous reported quarter. Mitsubishi Ufj Trust & Banking Corp who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $349.43 billion market cap company. The stock increased 1.29% or $1.66 during the last trading session, reaching $130.28. About 7.64M shares traded or 17.08% up from the average. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since July 27, 2017 and is downtrending. It has underperformed by 17.32% the S&P500.

Mitsubishi Ufj Trust & Banking Corp, which manages about $56.56B US Long portfolio, decreased its stake in Huntington Bancshare (NASDAQ:HBAN) by 309,625 shares to 2.19M shares, valued at $33.09M in 2018Q1, according to the filing. It also reduced its holding in Ishares Iboxx \ H/Y (HYG) by 1.99 million shares in the quarter, leaving it with 39,210 shares, and cut its stake in Yandex Nv (NASDAQ:YNDX).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Benzinga.com which released: “Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings” on July 12, 2018, also Seekingalpha.com with their article: “Johnson & Johnson – Aristocrat Looks Appealing” published on July 22, 2018, Fool.com published: “Did This Top Biotech Stock Just Go on Sale?” on July 25, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Johnson & Johnson (JNJ) CEO Alex Gorsky on Q2 2018 Results – Earnings Call Transcript” published on July 17, 2018 as well as Seekingalpha.com‘s news article titled: “J&J Wants A Piece Of Gilead’s HIV Market” with publication date: July 24, 2018.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 10 analysts covering Johnson & Johnson (NYSE:JNJ), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Johnson & Johnson had 16 analyst reports since February 6, 2018 according to SRatingsIntel. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Tuesday, February 6 by Wells Fargo. The firm earned “Equal-Weight” rating on Tuesday, April 10 by Morgan Stanley. Leerink Swann maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, April 18. Leerink Swann has “Buy” rating and $16000 target. The firm has “Neutral” rating by Goldman Sachs given on Thursday, July 12. The stock has “Buy” rating by Credit Suisse on Thursday, April 12. Jefferies maintained it with “Buy” rating and $15300 target in Friday, April 13 report. The stock has “Buy” rating by Jefferies on Friday, March 23. The stock has “Buy” rating by Deutsche Bank on Wednesday, April 18. Credit Suisse maintained the stock with “Outperform” rating in Friday, April 20 report. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Jefferies on Monday, February 26.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.